BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17900277)

  • 1. Correlation between serology and genetics of weak D types in Denmark.
    Christiansen M; Samuelsen B; Christiansen L; Morbjerg T; Bredahl C; Grunnet N
    Transfusion; 2008 Jan; 48(1):187-93. PubMed ID: 17900277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt.
    Abdelrazik AM; Elshafie SM; Ezzat Ahmed GM; Abdelaziz HM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2940-4. PubMed ID: 23362929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak D phenotypes and transfusion safety: where do we stand in daily practice?
    Noizat-Pirenne F; Verdier M; Lejealle A; Mercadier A; Bonin P; Peltier-Pujol F; Fialaire-Legendre A; Tournamille C; Bierling P; Ansart-Pirenne H
    Transfusion; 2007 Sep; 47(9):1616-20. PubMed ID: 17725725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHCE alleles detected after weak and/or discrepant results in automated Rh blood grouping of blood donors in Northern Germany.
    Döscher A; Vogt C; Bittner R; Gerdes I; Petershofen EK; Wagner FF
    Transfusion; 2009 Sep; 49(9):1803-11. PubMed ID: 19453979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHD positive among C/E+ and D- blood donors in Denmark.
    Christiansen M; Sørensen BS; Grunnet N
    Transfusion; 2010 Jul; 50(7):1460-4. PubMed ID: 20456676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
    Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
    Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I manage donors and patients with a weak D phenotype.
    Flegel WA
    Curr Opin Hematol; 2006 Nov; 13(6):476-83. PubMed ID: 17053462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles.
    Silvy M; Simon S; Gouvitsos J; Di Cristofaro J; Ferrera V; Chiaroni J; Bailly P
    Transfusion; 2011 Feb; 51(2):401-11. PubMed ID: 20723165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunohematologic routine methods using the new erythrocyte-magnetized technology on the QWALYS 2 system.
    Schoenfeld H; Bulling K; von Heymann C; Neuner B; Kalus U; Kiesewetter H; Pruss A
    Transfusion; 2009 Jul; 49(7):1347-52. PubMed ID: 19389030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte-magnetized technology: an original and innovative method for blood group serology.
    Bouix O; Ferrera V; Delamaire M; Redersdorff JC; Roubinet F
    Transfusion; 2008 Sep; 48(9):1878-85. PubMed ID: 18522706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood group genotyping in Germany.
    Flegel WA
    Transfusion; 2007 Jul; 47(1 Suppl):47S-53S. PubMed ID: 17593286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weak D and partial D in Slovenian population through serology and genotyping.
    Rupreht RR; Pretnar Hartman K; Galvani V; Rozman P; Curin Serbec V
    Pflugers Arch; 2000; 440(5 Suppl):R195-6. PubMed ID: 11005669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.